Precision Therapeutics Inc. company info

CIK 1446159
IRS Number 331007393
State of incorporation DE
Business address 2915 COMMERS DRIVE,
SUITE 900
EAGAN
MN
55121
Mail address 2915 COMMERS DRIVE,
SUITE 900
EAGAN
MN
55121

Short summary

Precision Therapeutics Inc. is a Minnesota company, with head office located at 2915 Commers Drive, Eagan, Minnesota 55121. In 2017 the company owned a total of 4.00 million USD worth of assets, including 2.01 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

Precision Therapeutics Inc. Income Statement

Name [in Millions USD]20012002200320042005200620072008200920102011201220132014201520162017Trends
Gross Profit 0.010.000.040.060.280.570.350.270.51
Research and development 0.100.0100.020.240.390.260.410.29
Interest expense 0.080.150.230.260.640.380.390.00
Income Tax Expense (Benefit) 000
Net income -1.35-0.48-7.42-9.41-6.83

Precision Therapeutics Inc. Balance Sheet

Name [in Millions USD]20012002200320042005200620072008200920102011201220132014201520162017Trends
Cash and cash equivalents 00.460.010.060.040.140.040.040.581.161.00
Accounts Receivable, Net, Current 0.020.000.030.100.150.020.020.050.32
Inventories 00.100.110.360.260.290.240.24
Property, Plant and Equipment, Gross 0.010.250.260.300.360.49
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.010.040.110.180.250.31
Intangible Assets, Net (Excluding Goodwill) 0.140.140.140.050.070.080.100.090.12
Total assets 0.290.250.380.440.970.752.894.534.00
Current assets 0.140.100.230.380.700.522.684.332.01
Accounts payable 0.810.730.660.661.632.470.750.060.17
Total current liabilities 0.481.431.922.453.393.916.891.551.260.93
Long-term Debt, Excluding Current Maturities 0.130.660.0900
Total liabilities 3.674.206.892.111.330.64
Common Stock, Value, Issued 0.110.240.671.222.230.030.780.060.12
Retained Earnings (Accumulated Deficit) 0.01-35.64-45.23-50.90-58.90
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.01

Precision Therapeutics Inc. Cash Flow

Name [in Millions USD]20012002200320042005200620072008200920102011201220132014201520162017Trends
Net income -1.35-0.48-7.42-9.41-6.83
Depreciation 0.000.000.000.000.150.060.070.070.06
Amortization of Intangible Assets 0.140.010.010.01
Depreciation and amortization 0.150.060.080.080.07
Accounts receivable 0.02-0.020.05-0.010.06-0.04-0.020.000.10
Inventories 00.100.05-0.020.25-0.140.04-0.01
Accounts payable 1.13-1.54-0.43-0.08
Deferred revenue 00.07-0.060.00-0.00
Net Cash Provided by (Used in) Operating Activities -1.31-0.82-1.78-1.18-4.38-4.46
Payments to Acquire Property, Plant, and Equipment 00000.160.100.030.030.05
Payments to Acquire Intangible Assets 00000.050.020.030.010.01
Net Cash Provided by (Used in) Investing Activities 0000-0.42-1.65
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0-0.22-0.12-0.06-0.42
Proceeds from Issuance of Long-term Debt 0.100.600.530.531.821.50
Proceeds from Issuance of Common Stock 0.630.221.390.702.340.1613.051.713.81
Payments for Repurchase of Common Stock -0.170
Net Cash Provided by (Used in) Financing Activities 0.860.811.901.071.715.11
Cash and Cash Equivalents, Period Increase (Decrease) -0.45-0.010.11-0.110.09-0.09